The hospital operator’s adjusted EBITDAR for the third quarter totaled $204.7 million, which includes $3.5 million of compensation expense associated with a bonus paid to certain members of the company’s leadership team. ISIS’ adjusted EBITDAR for the first nine months of 2013 was $195.8.
The cash flows used by the company for continuing operations for the first nine months of fiscal year 2014 totaled $3.4 million, compared to $8.9 million in the same period in 2013.
More articles on healthcare finance:
What will states lose by not expanding Medicaid?
Does more value mean less profit? How to keep pay-for-performance from hurting hospital income
9 recent hospital capital projects
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
